Oxygenta Pharmaceutical Limited manufactures and sells pharmaceutical, medical, and veterinary preparations in India. It offers active pharmaceuticals ingredients and commercial intermediates. The company was formerly known as S.S. Organics Limited and changed its name to Oxygenta Pharmaceutical Limited in February 2022. Oxygenta Pharmaceutical Limited was incorporated in 1990 and is based in Hyderabad, India.
| Current Price | ₹50.49 |
|---|---|
| Market Cap | ₹176 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Products |
| P/E Ratio | -10 |
| Return on Equity | 51.90% |
| 52-Week Range | ₹43.00 – ₹124.05 |
| Beta (1Y) | 0.7 |
1. Manufacturing of Pharmaceutical Products-100%
Oxygenta Pharmaceutical Ltd is trading at ₹50.49, with a market capitalisation of ₹176 Cr.
Oxygenta Pharmaceutical Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Products).
Oxygenta Pharmaceutical Ltd has a P/E of -10 and a return on equity of 51.90%.